Tech Company Financing Transactions
BioVex Funding Round
BioVex closed a $22 million Series E financing round on 7/9/2007. Investors included Triathlon Medical Ventures, Avalon Ventures and Credit Agricole Private Equity.
Transaction Overview
Company Name
Announced On
7/9/2007
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series E
Investors
Proceeds Purpose
Philip Astley-Sparke, President & CEO for BioVex Inc said: "Building on the impressive data that has recently been generated with our lead cancer product, OncoVEX GM-CSF , in the clinic, the funds raised in this round will allow us to complete our Phase II program and to complete preparations to advance OncoVEX GM-CSF into a registration study in metastatic melanoma. The funds will also be used to progress our lead infectious disease candidate, a vaccine for genital herpes, through to Phase II."
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
34 Commerce Way
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Overview
The Company is developing a new class of potent biologics for the treatmentof cancer and prevention of infectious disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Philip Astley-Sparke
Chief Financial Officer
Stephen Gorgol
Chief Medical Officer
Howard Goldsweig
Chief Technical Officer
Robert Coffin
VP - Bus. Development
Pamela Esposito
VP - Manufacturing
Paul Bullock
VP - Operations
Timothy Hanke
VP - Operations
Lance Weed
VP - Product Management
Colin Love
VP - Regulatory Affairs
Anne Woodland
Browse more venture capital transactions:
Prev: 7/9/2007: PerfAction Technologies venture capital transaction
Next: 7/9/2007: GaimTheory venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs